Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Physiological metalloproteins and metalloenzymes are a vast and diverse class of proteins that incorporate metal ions as essential cofactors for their structural integrity and biological activity [2, 4]. These proteins utilize metals such as iron, zinc, copper, magnesium, and manganese to perform critical functions including oxygen transport (e.g., hemoglobin), electron transfer (e.g., cytochromes), and catalysis of complex biochemical reactions (e.g., carbonic anhydrase and matrix metalloproteinases) [1, 3, 5]. In disease, dysregulation of these proteins or the underlying metal homeostasis is linked to conditions ranging from cancer and inflammation to neurodegenerative and cardiovascular diseases [4, 8]. Therapeutic strategies often involve small molecules with metal-binding pharmacophores designed to inhibit specific metalloenzymes by coordinating with the active-site metal ion [8]. However, achieving selectivity remains a significant challenge due to the structural similarities among different metal-binding sites, leading to potential off-target effects and toxicity [6, 8].
Drugs targeting this class typically utilize metal-binding pharmacophores to coordinate with the active-site metal ion, inhibiting catalytic activity or blocking substrate binding [8]. Mechanisms also include competitive inhibition and modulation of metal ion coordination geometry [6].
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Physiological metalloproteins and metalloenzymes.